GTPase HRas: Difference between revisions

Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 1: Line 1:
<StructureSection load='5p21' size='500' side='right' caption='Human RAS P21 complex with Mg+2 and phosphoamino phosphonic guanylate [[5p21]]'>
<StructureSection load='1nvu' size='500' side='right' caption='Human RAS P21 complex with Mg+2 and phosphoamino phosphonic guanylate [[1nvu]]'>
[[Image:Hras.png|200px|left|]]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ''RAS'' gene family was discovered due to the presence of two closely related retroviral cancer genes (oncogenes) within the Harvey and Kirsten '''RA'''t '''S'''arcoma viruses.  These retroviral oncogenes arose via capture of two normal cellular genes, ''H-RAS'' and ''K-RAS''.  A [[DNA]] transfection assay for [[Oncogenes|oncogenes]] in human bladder cancer later identified the same ''H-RAS'' gene. Remarkably, the mutated oncogenic form of ''H-RAS'' differed from its normal counterpart by a single nucleotide change that caused a single amino acid substitution.  Biochemical studies of purified RAS proteins revealed that they were capable of binding nucleotides, with a particularly high affinity for GTP. Extensive genetic, biochemical, and structural studies have established a model in which the RAS proteins function as molecular switches, as do related GTP-binding proteins.  The RAS switch is "ON" when it binds <scene name='User:Joseph_Lipsick/RAS/Ras-gtp_switches/5'>GTP</scene>, and is "OFF" when it binds <scene name='User:Joseph_Lipsick/RAS/Ras-gdp_switches/11'>GDP</scene>. The changes in protein conformation between the <scene name='User:Joseph_Lipsick/RAS/Ras-gtp_switch_i_ii_spacefill/2'>"ON"</scene> and <scene name='User:Joseph_Lipsick/RAS/Ras-gdp_switch_i_ii_spacefill/3'>"OFF"</scene> states are not very large.  These changes primarily occur in two regions known as SWITCH I (yellow) and SWITCH II (magenta), and can be visualized by toggling the spin off and on in these partial space-filling models.  The RAS protein itself has an intrinsic GTPase activity, thereby limiting the duration of time spent in the "ON" configuration.  The binding sites of the nucleotide and the magnesium ion are revealed in high detail and consists of a characteristic <scene name='5p21/Ligand_binding_site/1'>Walker motif</scene> (GXXXXGK[T/S]).  For additional details see [[H-RasK117R mutant]] and [[User:Joseph Lipsick/RAS]].
[[Image:Hras.png|200px|left|]]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ''RAS'' gene family was discovered due to the presence of two closely related retroviral cancer genes (oncogenes) within the Harvey and Kirsten '''RA'''t '''S'''arcoma viruses.  These retroviral oncogenes arose via capture of two normal cellular genes, ''H-RAS'' and ''K-RAS''.  A [[DNA]] transfection assay for [[Oncogenes|oncogenes]] in human bladder cancer later identified the same ''H-RAS'' gene. Remarkably, the mutated oncogenic form of ''H-RAS'' differed from its normal counterpart by a single nucleotide change that caused a single amino acid substitution.  Biochemical studies of purified RAS proteins revealed that they were capable of binding nucleotides, with a particularly high affinity for GTP. Extensive genetic, biochemical, and structural studies have established a model in which the RAS proteins function as molecular switches, as do related GTP-binding proteins.  The RAS switch is "ON" when it binds <scene name='User:Joseph_Lipsick/RAS/Ras-gtp_switches/5'>GTP</scene>, and is "OFF" when it binds <scene name='User:Joseph_Lipsick/RAS/Ras-gdp_switches/11'>GDP</scene>. The changes in protein conformation between the <scene name='User:Joseph_Lipsick/RAS/Ras-gtp_switch_i_ii_spacefill/2'>"ON"</scene> and <scene name='User:Joseph_Lipsick/RAS/Ras-gdp_switch_i_ii_spacefill/3'>"OFF"</scene> states are not very large.  These changes primarily occur in two regions known as SWITCH I (yellow) and SWITCH II (magenta), and can be visualized by toggling the spin off and on in these partial space-filling models.  The RAS protein itself has an intrinsic GTPase activity, thereby limiting the duration of time spent in the "ON" configuration.  The binding sites of the nucleotide and the magnesium ion are revealed in high detail and consists of a characteristic <scene name='5p21/Ligand_binding_site/1'>Walker motif</scene> (GXXXXGK[T/S]).  For additional details see [[H-RasK117R mutant]] and [[User:Joseph Lipsick/RAS]].


Line 25: Line 25:
[[1p2s]], [[1p2u]], [[1p2v]], [[3rrz]], [[3rs0]], [[3rs2]], [[3rs4]], [[3rs7]], [[3rsl]], [[3rso]] - hHRAS catalytic domain + alcohol + guanylate derivative<br / >
[[1p2s]], [[1p2u]], [[1p2v]], [[3rrz]], [[3rs0]], [[3rs2]], [[3rs4]], [[3rs7]], [[3rsl]], [[3rso]] - hHRAS catalytic domain + alcohol + guanylate derivative<br / >
[[3rs3]], [[3rs5]] - hHRAS catalytic domain + small organic molecule + guanylate derivative<br / >
[[3rs3]], [[3rs5]] - hHRAS catalytic domain + small organic molecule + guanylate derivative<br / >
[[3ibh]], [[3lbi]], [[3lbn]] - hHRAS catalytic domain + salt + guanylate derivative<br / >
[[3lbh]], [[3lbi]], [[3lbn]] - hHRAS catalytic domain + salt + guanylate derivative<br / >
[[3l8y]] - hHRAS catalytic domain + cyclen + guanylate derivative<br / >
[[3l8y]] - hHRAS catalytic domain + cyclen + guanylate derivative<br / >
[[1clu]], [[1rvd]], [[1iaq]], [[1gnr]] - hHRAS catalytic domain (mutant) + GTP derivative<br / >
[[1clu]], [[1rvd]], [[1iaq]], [[1gnr]] - hHRAS catalytic domain (mutant) + GTP derivative<br / >

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Joseph Lipsick, David Canner, Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman